INTRODUCTIONIn a sense, the majority of surgical procedures performed in patients with retroperitoneal sarcoma (RPS) could be regarded as “palliative.” Large surgical series with long‐term follow‐up have shown that while the recurrence rate is highest within the first two years following complete resection of primary RPS, recurrences continue to occur 15‐20 years later, with no apparent plateau. The very long‐term recurrence‐free survival rate is less than 25% in such series. For recurrent RPS, whether local or distant, the disease‐specific survival rates following resection are worse still. However, recent improvements in the quality of surgical resection may translate to improved long‐term outcomes. In keeping with the latter expectation, a consensus statement by the Trans‐Atlantic RPS working group (TARPSWG) emphasizes that the best chance of curative resection is at time of primary presentation, with discussion of every patient at a multidisciplinary sarcoma conference where adjuvant therapies can be considered as the optimal approach to “curative‐intent” management is developed for the individual patient. By contrast, the role of surgery in patients who are not eligible for a curative approach is fraught with uncertainty and controversy.The term “palliative care” was first coined in 1975 by Balfour Mount, a Canadian urologist who started a
Journal of Surgical Oncology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
It’s easy to organize your research with our built-in tools.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud